BioAge Labs (BIOA) Interest Coverage Ratio (2023 - 2026)
BioAge Labs' (BIOA) quarterly Interest Coverage Ratio came in at 29333.0 in Q2 2026, down 23701.76% year-over-year from N/an in Q2 2025, and down 4408.32% quarter-over-quarter from 650.64 in Q1 2026.
Powered by 
Analysis
BioAge Labs (BIOA) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Interest Coverage Ratio across 4 years of filings, most recently posting 29333.0 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 23701.76% year-over-year to 29333.0; the TTM figure through Jun 2026 stood at 378.19 (down 381.59% YoY), while the FY2025 annual figure was 133.11, down 302.95% from the prior year.
- Interest Coverage Ratio came in at 29333.0 for Q2 2026 at BioAge Labs, down from 650.64 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 4.11 in Q3 2023 to a low of 29333.0 in Q2 2026.
- Average Interest Coverage Ratio over 4 years is 2569.44, with a median of 72.0 recorded in 2024.
- Year-over-year, Interest Coverage Ratio plunged 143.46% in 2025 and plunged 23701.76% in 2026.
- Over 4 years, Interest Coverage Ratio stood at 5.31 in 2023, then sank by 1396.41% to 79.5 in 2024, then slumped by 288.59% to 308.95 in 2025, then plunged by 9394.55% to 29333.0 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 29333.0 in Q2 2026, 650.64 in Q1 2026, and 308.95 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | BioAge Labs | 409.83 Mn | 409.83 Mn | -14.23 Mn | -29,333.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29,333.00 |
| Mar 31, 2026 | -650.64 |
| Dec 31, 2025 | -308.95 |
| Sep 30, 2025 | -155.30 |
| Jun 30, 2025 | -123.24 |
| Mar 31, 2025 | -64.49 |
| Dec 31, 2024 | -79.50 |
| Sep 30, 2024 | -63.79 |
| Jun 30, 2024 | -34.47 |
| Mar 31, 2024 | -10.53 |
| Dec 31, 2023 | -5.31 |
| Sep 30, 2023 | -4.11 |